Pfizer (PFE) Reports Encouraging Top-Line Data from ORAL Start; FDA Requests Additional Info for Tofacitinib NDA

Go back to Pfizer (PFE) Reports Encouraging Top-Line Data from ORAL Start; FDA Requests Additional Info for Tofacitinib NDA